nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—Iron deficiency anaemia—Riluzole—amyotrophic lateral sclerosis	0.0488	0.0494	CcSEcCtD
Raltegravir—Major depression—Riluzole—amyotrophic lateral sclerosis	0.0411	0.0416	CcSEcCtD
Raltegravir—Nephritis—Riluzole—amyotrophic lateral sclerosis	0.0324	0.0328	CcSEcCtD
Raltegravir—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0223	0.0225	CcSEcCtD
Raltegravir—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0205	CcSEcCtD
Raltegravir—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0198	0.02	CcSEcCtD
Raltegravir—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0198	CcSEcCtD
Raltegravir—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0191	CcSEcCtD
Raltegravir—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0189	CcSEcCtD
Raltegravir—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0184	CcSEcCtD
Raltegravir—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0168	CcSEcCtD
Raltegravir—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0165	CcSEcCtD
Raltegravir—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0163	CcSEcCtD
Raltegravir—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0138	0.014	CcSEcCtD
Raltegravir—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0138	CcSEcCtD
Raltegravir—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0129	0.013	CcSEcCtD
Raltegravir—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0124	CcSEcCtD
Raltegravir—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.012	0.0122	CcSEcCtD
Raltegravir—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0121	CcSEcCtD
Raltegravir—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0119	CcSEcCtD
Raltegravir—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0119	CcSEcCtD
Raltegravir—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0114	CcSEcCtD
Raltegravir—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0112	CcSEcCtD
Raltegravir—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0112	CcSEcCtD
Raltegravir—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0111	CcSEcCtD
Raltegravir—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0108	CcSEcCtD
Raltegravir—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.01	0.0101	CcSEcCtD
Raltegravir—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00961	0.00973	CcSEcCtD
Raltegravir—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00942	0.00954	CcSEcCtD
Raltegravir—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00924	0.00936	CcSEcCtD
Raltegravir—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00924	0.00936	CcSEcCtD
Raltegravir—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00856	0.00866	CcSEcCtD
Raltegravir—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00856	0.00866	CcSEcCtD
Raltegravir—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00827	0.00838	CcSEcCtD
Raltegravir—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00791	0.00801	CcSEcCtD
Raltegravir—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00791	0.00801	CcSEcCtD
Raltegravir—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00785	0.00795	CcSEcCtD
Raltegravir—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00776	0.00786	CcSEcCtD
Raltegravir—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00762	0.00771	CcSEcCtD
Raltegravir—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00736	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00724	0.00733	CcSEcCtD
Raltegravir—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00712	0.0072	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00709	0.00718	CcSEcCtD
Raltegravir—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.007	0.00708	CcSEcCtD
Raltegravir—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00695	0.00704	CcSEcCtD
Raltegravir—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00677	CcSEcCtD
Raltegravir—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00674	CcSEcCtD
Raltegravir—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0065	0.00658	CcSEcCtD
Raltegravir—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00648	CcSEcCtD
Raltegravir—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0064	CcSEcCtD
Raltegravir—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00629	0.00637	CcSEcCtD
Raltegravir—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00627	CcSEcCtD
Raltegravir—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00627	CcSEcCtD
Raltegravir—Depression—Riluzole—amyotrophic lateral sclerosis	0.00618	0.00626	CcSEcCtD
Raltegravir—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00611	0.00618	CcSEcCtD
Raltegravir—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00607	0.00615	CcSEcCtD
Raltegravir—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00607	0.00615	CcSEcCtD
Raltegravir—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00591	0.00598	CcSEcCtD
Raltegravir—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00593	CcSEcCtD
Raltegravir—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00592	CcSEcCtD
Raltegravir—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00563	CcSEcCtD
Raltegravir—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0056	CcSEcCtD
Raltegravir—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0056	CcSEcCtD
Raltegravir—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00556	CcSEcCtD
Raltegravir—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00555	CcSEcCtD
Raltegravir—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00553	CcSEcCtD
Raltegravir—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00545	0.00552	CcSEcCtD
Raltegravir—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00532	CcSEcCtD
Raltegravir—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00526	CcSEcCtD
Raltegravir—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00523	CcSEcCtD
Raltegravir—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00505	0.00511	CcSEcCtD
Raltegravir—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00509	CcSEcCtD
Raltegravir—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00508	CcSEcCtD
Raltegravir—Chills—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00505	CcSEcCtD
Raltegravir—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00498	CcSEcCtD
Raltegravir—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00493	CcSEcCtD
Raltegravir—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00484	0.0049	CcSEcCtD
Raltegravir—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00483	CcSEcCtD
Raltegravir—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0048	CcSEcCtD
Raltegravir—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00476	CcSEcCtD
Raltegravir—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00474	CcSEcCtD
Raltegravir—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00459	CcSEcCtD
Raltegravir—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00455	CcSEcCtD
Raltegravir—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00453	CcSEcCtD
Raltegravir—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00451	CcSEcCtD
Raltegravir—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00442	CcSEcCtD
Raltegravir—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00435	0.0044	CcSEcCtD
Raltegravir—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00433	CcSEcCtD
Raltegravir—Cough—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00428	CcSEcCtD
Raltegravir—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00418	0.00423	CcSEcCtD
Raltegravir—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00417	CcSEcCtD
Raltegravir—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00417	CcSEcCtD
Raltegravir—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00417	CcSEcCtD
Raltegravir—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00416	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00414	CcSEcCtD
Raltegravir—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00412	CcSEcCtD
Raltegravir—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00408	CcSEcCtD
Raltegravir—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00403	CcSEcCtD
Raltegravir—Infection—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00397	CcSEcCtD
Raltegravir—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00392	CcSEcCtD
Raltegravir—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00392	CcSEcCtD
Raltegravir—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00389	CcSEcCtD
Raltegravir—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00387	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00365	CcSEcCtD
Raltegravir—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00362	CcSEcCtD
Raltegravir—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00359	CcSEcCtD
Raltegravir—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00356	CcSEcCtD
Raltegravir—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00352	CcSEcCtD
Raltegravir—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00348	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00345	CcSEcCtD
Raltegravir—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00345	CcSEcCtD
Raltegravir—Pain—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00342	CcSEcCtD
Raltegravir—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00342	CcSEcCtD
Raltegravir—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00326	0.0033	CcSEcCtD
Raltegravir—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00327	CcSEcCtD
Raltegravir—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00318	CcSEcCtD
Raltegravir—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00316	CcSEcCtD
Raltegravir—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00316	CcSEcCtD
Raltegravir—CCR1—medulla oblongata—amyotrophic lateral sclerosis	0.00311	0.254	CbGeAlD
Raltegravir—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00295	CcSEcCtD
Raltegravir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00287	CcSEcCtD
Raltegravir—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00283	CcSEcCtD
Raltegravir—CCR1—spinal cord—amyotrophic lateral sclerosis	0.00278	0.226	CbGeAlD
Raltegravir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00274	CcSEcCtD
Raltegravir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00265	CcSEcCtD
Raltegravir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00254	CcSEcCtD
Raltegravir—Rash—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00252	CcSEcCtD
Raltegravir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00252	CcSEcCtD
Raltegravir—Headache—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00251	CcSEcCtD
Raltegravir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00238	CcSEcCtD
Raltegravir—CCR1—nervous system—amyotrophic lateral sclerosis	0.00234	0.191	CbGeAlD
Raltegravir—CCR1—central nervous system—amyotrophic lateral sclerosis	0.00225	0.184	CbGeAlD
Raltegravir—CCR1—brain—amyotrophic lateral sclerosis	0.00179	0.146	CbGeAlD
